Spectral Diagnostics, a Canadian biotech shop, hopes to use approximately $8 million in cash and other investments to develop an in vitro diagnostic for West Nile virus that health-care workers can employ in the field, a company official told SNPtech Reporter.

While an immunoassay for the pathogen is currently approved for use in the United States, the test proposed by Spectral Diagnostics will require smaller blood samples, and may be able to provide results in minutes rather than hours or days.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.